Advanced Inhaled Therapies For Global Health
Experts in the development of inhaled medicines, we are passionate about generating better outcomes for patients globally.
Get in touch
Our Mission
To develop innovative inhalation therapies that offer rapid, reliable, and non-invasive treatment options for underserved conditions.
Our Vision
To enhance the quality of life for tens of millions by providing effective and affordable solutions to every corner of the world.
The Problem
Volatile actives are challenging to reliably administer

1

The lungs are a superhighway to the body.
Pulmonary delivery of medications plays a crucial role in treating conditions that benefit from a rapid onset of action, enhanced bioavailability, or a non-invasive route of administration.

2

However, the lungs are delicate organs.
Formulating drugs for delivery to the lungs requires the thoughtful selection of ingredients and components to optimise particle size distribution for deep lung deposition while ensuring safety and chemical stability.

3

And volatile actives are unpredictable.
Volatile active ingredients present even greater challenges for lung delivery. These molecules vaporise rapidly when released as an aerosol, leading to inconsistent dose delivery to the lower lungs.
Our Solution
A platform for encapsulating volatiles in pMDIs
Inhaled Solutions has developed a patent-pending technique for pressurised metered dose inhalers that enables the encapsulation of volatile molecules within droplets of respirable size.
Our approach delays release of the active by combining excipients of varying densities to hold the active in the centre of droplets while outer layers evaporate off.
This reduces the premature escape of the active dose into the atmosphere and minimises oropharyngeal deposition, which can cause local irritation or metabolism in the gastrointestinal tract.
Use Cases
Smoking Cessation
Next-generation nicotine replacement therapy (NRT) for discreet and effective craving relief.
Pain Relief
Non-opioid analgesics for the rapid relief of pain in emergency settings.
Cardiac Care
Improved shelf life stability and rapid-response treatment for angina.
Benefits of Our Platform
Enabling Innovation
Our platform enables the formulation of drugs that have traditionally been challenging to develop for pulmonary delivery.
Better Patient Outcomes
Highly controlled particle size distribution delivers more dose to desirable regions of the lungs, improving efficacy and reducing side-effects.
Accessible to All
Up to 200 doses in a low-cost and shelf-stable device means our products can be accessible to everyone, not just those in wealthy countries.
Got an idea?
Develop Your Product With Us
Inhaled Solutions' team and network of partners possess world-leading expertise in the development of nasal and inhalation drug-device combination products, and can support your development from idea through to commercial success.
Formulation
  • Drug delivery optimisation
  • Excipient selection
  • Device screening
  • Custom device development
  • Stability validation
  • IP registration support
Clinical Stage
  • Tech transfer support
  • Clinical trial manufacture
  • R&D tax incentive claims and financing
  • CRO and site sourcing
  • KOL search
Commercial
  • Go to market strategy
  • Commercial manufacturer sourcing
  • Partner scouting
  • Regulatory support
Contact Us
Inhaler Supplies Pty Ltd
Level 3, 360 Kent St
Sydney NSW 2000
Australia
Made with Gamma